Volume 27, Number 8—August 2021
Dispatch
Autochthonous Cases of Tick-Borne Encephalitis, Belgium, 2020
Table
Laboratory results confirming TBEV infections in 3 autochthonous human cases, Belgium, 2020
Case no. | Symptom onset date | Exposure |
Sample type, days after symptom onset | Flavivirus IFA |
PRNT90 titer | rRT-PCR | ||
---|---|---|---|---|---|---|---|---|
Likely site, postal code | Likely route, time | IgM† | IgG‡ | |||||
1 | Jun 5 | Oostkamp, 8020 | Tick bite, 2 wk before symptom onset |
Serum, 5 | TBEV+ | TBEV+ | 1:25 | ND |
CSF, 6 |
TBEV+ |
TBEV+ |
ND |
ND |
||||
2 | Jun 21 | Lille, 2275 | Tick bite, 2 wk before symptom onset |
CSF, 18 | TBEV+ | TBEV+ | ND | ND |
Serum, 20 |
TBEV+ |
TBEV+ |
1:60 |
ND |
||||
3 | Jul 20 | Wanze, 4520 | Multiple tick bites in the weeks before symptom onset | Serum, 2 | – | – | ND | + |
Serum, 18 | TBEV+ | TBEV+ | 1:194 | ND |
*CSF, cerebrospinal fluid; IFA, immunofluorescence assay; ND, not done; PRNT90, plaque reduction neutralization testing at 90% sensitivity; rRT-PCR, real-time reverse transcription PCR; TBEV, tick-borne encephalitis virus; +, positive; –, negative. †Only TBEV-positive on the flavivirus mosaic IFA. ‡Also positive signal for >1 other flavivirus on the mosaic IFA, including West Nile virus, Japanese encephalitis virus, yellow fever virus, and dengue virus serotypes 1–4.